TC BioPharm (Holdings) plc American Depositary Shares
TCBP
TCBP was delisted on the 21st of March, 2025.
6 hedge funds and large institutions have $77K invested in TC BioPharm (Holdings) plc American Depositary Shares in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
81% more capital invested
Capital invested by funds: $42.6K → $77K (+$34.4K)
50% more funds holding
Funds holding: 4 → 6 (+2)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$28.2K |
| 2 |
S
SignatureFD
Atlanta,
Georgia
|
+$7.4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.2K |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$23K |
| 2 |
CAG
Csenge Advisory Group
Clearwater,
Florida
|
-$3.2K |
| 3 |
HT
Headlands Technologies
Chicago,
Illinois
|
-$200 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PTP
1
Platform Technology Partners
New York
| $41.2K | +$62.6K | +313 | New |
|
|
2
Citadel Advisors
Miami,
Florida
| $18.5K | +$28.2K | +141 | New |
|
|
CAG
3
Csenge Advisory Group
Clearwater,
Florida
| $9.89K | -$3.2K | -16 | -18% |
|
|
S
4
SignatureFD
Atlanta,
Georgia
| $4.91K | +$7.4K | +37 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $1.73K | +$2.2K | +11 | +550% |
|
|
6
RhumbLine Advisers
Boston,
Massachusetts
| $691 | +$1K | +5 | New |
|
7
Wells Fargo
San Francisco,
California
| $41 | – | – | – |
|
|
HT
8
Headlands Technologies
Chicago,
Illinois
| $2 | -$200 | -1 | Closed |
|
|
VF
9
Virtu Financial
New York
| – | -$23K | -112 | Closed |
|
TCBP Hedge Fund Activity: Q2 2024 in Review
6 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc American Depositary Shares (TCBP) for Q2 2024, worth a combined $77K — up 81% from $42.6K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new TCBP positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $28.2K. The largest seller was Virtu Financial, exiting entirely with an estimated $23K sold.
- 6 institutional investors held TC BioPharm (Holdings) plc American Depositary Shares (TCBP) as of Q2 2024, up from 4 in Q1 2024.
- Funds reported $77K of TC BioPharm (Holdings) plc American Depositary Shares stock for Q2 2024, up 81% quarter-over-quarter.
- 4 funds opened new TC BioPharm (Holdings) plc American Depositary Shares positions in Q2 2024 and 2 closed out, a net change of +2 holders.
- The largest TC BioPharm (Holdings) plc American Depositary Shares buyer in Q2 2024 was Citadel Advisors, an estimated $28.2K added.
- The largest TC BioPharm (Holdings) plc American Depositary Shares seller in Q2 2024 was Virtu Financial, an estimated $23K sold.
Based on aggregated 13F filings for Q2 2024.